Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Gastroenterology
•
General Hepatology
How would you approach the workup of a patient with a history of HCC post-TARE with a recent non-viable MRI but a new portal vein thrombosis?
Related Questions
How do you approach the workup for a patient with imaging showing features suggestive of cirrhosis?
Which GI cancer patients do you use oral contrast in staging CT scans?
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
Do you recommend CBD cessation prior to screening of liver enzymes?
In patients with MASLD and F2–F3 fibrosis, would you initiate Resmetirom even if they are not making active lifestyle changes?
How do you decide between anticoagulation or portal vein recanalization in a patient with portal vein thrombosis?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?